Get started
Author

Tao Zhang

Discovery of novel benzylidene-1,3-thiazolidine-2,4-diones as potent and selective inhibitors of the PIM-1, PIM-2, and PIM-3 protein kinases
2012 · Les A. Dakin, Michael H. Block, et al. · Bioorganic & Medicinal Chemistry Letters · 104
Colonic Crypt Changes during Adenoma Development in Familial Adenomatous Polyposis
2004 · Bruce M. Boman, Rhonda Walters, et al. · American Journal Of Pathology · 91
PDF
Huaier aqueous extract inhibits colorectal cancer stem cell growth partially via downregulation of the Wnt/β-catenin pathway
2013 · TAO ZHANG, KE WANG, et al. · Oncology Letters · 44
PDF
One-Hit Effects in Cancer: Altered Proteome of Morphologically Normal Colon Crypts in Familial Adenomatous Polyposis
2008 · Anthony T. Yeung, Bhavinkumar B. Patel, et al. · Cancer Research · 41
PDF
MicroRNA-375 represses tumor angiogenesis and reverses resistance to sorafenib in hepatocarcinoma
2020 · Dong Li, Tao Wang, et al. · Cancer Gene Therapy · 37
PDF
Expression of DNA damage checkpoint 53BP1 is correlated with prognosis, cell proliferation and apoptosis in colorectal cancer.
2015 · Jianping Bi, Ai Huang, et al. · PubMed · 30
Inhibition of MicroRNA-195 Alleviates Neuropathic Pain by Targeting Patched1 and Inhibiting SHH Signaling Pathway Activation
2019 · Xuhui Wang, Hong Wang, et al. · Neurochemical Research · 25
Low expression of RSK4 predicts poor prognosis in patients with colorectal cancer.
2014 · Jun Cai, Hong Ma, et al. · PubMed · 24
STAT3/TGFBI signaling promotes the temozolomide resistance of glioblastoma through upregulating glycolysis by inducing cellular senescence
2025 · Yanbin Zhang, Xiaohua Xiao, et al. · Cancer Cell International · 11
PDF
Exosomal miR-21-5p from glioma associated mesenchymal stem cells promotes the progression and glycolysis of glioblastoma via PDHA1
2025 · Yanbin Zhang, Peng Lv, et al. · Scientific Reports · 9
PDF
Abstract CT010: Phase I dose-escalation and expansion study of JS107, a claudin 18.2 (CLDN18.2)-targeting antibody-drug conjugate (ADC), as monotherapy or in combination for patients (pts) with advanced solid tumors
2025 · Rui-Hua Xu, Dan-Yun Ruan, et al. · Cancer Research · 5
Evolution of the ErbB gene family and analysis of regulators of Egfr expression during development of the rat spinal cord
2022 · Xiao-Song Gu, Jian Yang, et al. · Neural Regeneration Research · 5
Drug resistance‑related gene targets and molecular mechanisms in the A2780/Taxol‑resistant epithelial ovarian cancer cell line
2024 · Ruihui Yang, Huainian Zhang, et al. · Oncology Letters · 2
PDF
Cyclin L1 participates in Adriamycin resistance and progression of osteosarcoma via PI3K/AKT-mTOR pathway
2024 · Yanbin Zhang, Tao Zhang, et al. · Aging
Data from OSI-930: A Novel Selective Inhibitor of Kit and Kinase Insert Domain Receptor Tyrosine Kinases with Antitumor Activity in Mouse Xenograft Models
2023 · Andrew J. Garton, Andrew P.A. Crew, et al.
Supplementary Tables 1-2 from OSI-930: A Novel Selective Inhibitor of Kit and Kinase Insert Domain Receptor Tyrosine Kinases with Antitumor Activity in Mouse Xenograft Models
2023 · Andrew J. Garton, Andrew P.A. Crew, et al.
PDF
Supplementary Figures 1-3 from OSI-930: A Novel Selective Inhibitor of Kit and Kinase Insert Domain Receptor Tyrosine Kinases with Antitumor Activity in Mouse Xenograft Models
2023 · Andrew J. Garton, Andrew P.A. Crew, et al.
Supplementary Figures 1-3 from OSI-930: A Novel Selective Inhibitor of Kit and Kinase Insert Domain Receptor Tyrosine Kinases with Antitumor Activity in Mouse Xenograft Models
2023 · Andrew J. Garton, Andrew P.A. Crew, et al.
PDF
Supplementary Tables 1-2 from OSI-930: A Novel Selective Inhibitor of Kit and Kinase Insert Domain Receptor Tyrosine Kinases with Antitumor Activity in Mouse Xenograft Models
2023 · Andrew J. Garton, Andrew P.A. Crew, et al.
Supplementary Figure Legends from OSI-930: A Novel Selective Inhibitor of Kit and Kinase Insert Domain Receptor Tyrosine Kinases with Antitumor Activity in Mouse Xenograft Models
2023 · Andrew J. Garton, Andrew P.A. Crew, et al.
Supplementary Figure Legends from OSI-930: A Novel Selective Inhibitor of Kit and Kinase Insert Domain Receptor Tyrosine Kinases with Antitumor Activity in Mouse Xenograft Models
2023 · Andrew J. Garton, Andrew P.A. Crew, et al.
PDF
Data from OSI-930: A Novel Selective Inhibitor of Kit and Kinase Insert Domain Receptor Tyrosine Kinases with Antitumor Activity in Mouse Xenograft Models
2023 · Andrew J. Garton, Andrew P.A. Crew, et al.
Supplementary Data 1-13 from One-Hit Effects in Cancer: Altered Proteome of Morphologically Normal Colon Crypts in Familial Adenomatous Polyposis
2023 · Anthony T. Yeung, Bhavinkumar B. Patel, et al.
Supplementary Data 1-13 from One-Hit Effects in Cancer: Altered Proteome of Morphologically Normal Colon Crypts in Familial Adenomatous Polyposis
2023 · Anthony T. Yeung, Bhavinkumar B. Patel, et al.
PDF
Data from One-Hit Effects in Cancer: Altered Proteome of Morphologically Normal Colon Crypts in Familial Adenomatous Polyposis
2023 · Anthony T. Yeung, Bhavinkumar B. Patel, et al.
Works count: 28
Citation count: 428
H-index: 9
I10-index: 9
Year
Topic
Type